Exact Sciences Announces Second Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Exact Sciences (EXAS) Tops Q2 EPS by 11c
August 2, 2022 4:38 PM EDTExact Sciences (NASDAQ: EXAS) reported Q2 EPS of ($0.94), $0.11 better than the analyst estimate of ($1.05). Revenue for the quarter came in at $522 million versus the consensus estimate of $497.18 million.
GUIDANCE:
Exact Sciences sees Q3 2022 revenue of $1.98-2.022 billion, versus the consensus... More
